DE60025241D1 - HäMOPOIETINREZEPTOR-PROTEIN, NR12 - Google Patents

HäMOPOIETINREZEPTOR-PROTEIN, NR12

Info

Publication number
DE60025241D1
DE60025241D1 DE60025241T DE60025241T DE60025241D1 DE 60025241 D1 DE60025241 D1 DE 60025241D1 DE 60025241 T DE60025241 T DE 60025241T DE 60025241 T DE60025241 T DE 60025241T DE 60025241 D1 DE60025241 D1 DE 60025241D1
Authority
DE
Germany
Prior art keywords
receptor protein
hemopoietin receptor
hemopoietin
protein
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60025241T
Other languages
English (en)
Other versions
DE60025241T2 (de
Inventor
Masatsugu Maeda
Noriko Yaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DE60025241D1 publication Critical patent/DE60025241D1/de
Application granted granted Critical
Publication of DE60025241T2 publication Critical patent/DE60025241T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
DE60025241T 1999-09-27 2000-09-27 HäMOPOIETINREZEPTOR-PROTEIN, NR12 Expired - Lifetime DE60025241T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP27335899 1999-09-27
JP27335899 1999-09-27
JP2000240397 2000-08-03
JP2000240397 2000-08-03
PCT/JP2000/006654 WO2001023556A1 (fr) 1999-09-27 2000-09-27 Nouvelle proteine receptrice d'hemopoietine (nr12)

Publications (2)

Publication Number Publication Date
DE60025241D1 true DE60025241D1 (de) 2006-02-02
DE60025241T2 DE60025241T2 (de) 2007-01-11

Family

ID=26550628

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025241T Expired - Lifetime DE60025241T2 (de) 1999-09-27 2000-09-27 HäMOPOIETINREZEPTOR-PROTEIN, NR12

Country Status (6)

Country Link
US (9) US7045595B2 (de)
EP (1) EP1221482B1 (de)
AU (1) AU7445900A (de)
DE (1) DE60025241T2 (de)
ES (1) ES2254224T3 (de)
WO (1) WO2001023556A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1181366T4 (da) * 1999-06-01 2013-09-23 Merck Sharp & Dohme Mammale receptorproteiner, beslægtede reagenser og fremgangsmåder
ES2339843T3 (es) 1999-06-02 2010-05-26 Chugai Seiyaku Kabushiki Kaisha Proteina receptora de hematopoyetina novedosa, nr10.
AU2007202362B2 (en) * 1999-09-03 2011-06-23 Merck Sharp & Dohme Corp. Mammalian receptor proteins; related reagents and methods
ES2254224T3 (es) * 1999-09-27 2006-06-16 Chugai Seiyaku Kabushiki Kaisha Nueva proteina del receptor de hematopoyetina, nr12.
ES2307618T3 (es) 2000-05-10 2008-12-01 Schering Corporation Proteinas subunidades de receptores de cotocinas de mamiferos, reactivos y metodos relacionados.
US7422743B2 (en) * 2000-05-10 2008-09-09 Schering Corporation Mammalian receptor protein DCRS5;methods of treatment
AU2318202A (en) * 2000-10-06 2002-04-15 Immunex Corp Hematopoietin receptors hpr1 and hpr2
CA2501786C (en) 2002-10-30 2015-02-17 Genentech, Inc. Inhibition of il-17 production
WO2004101606A2 (en) * 2003-05-12 2004-11-25 Affymax, Inc. Novel peptides that bind to the erythropoietin receptor
KR101227666B1 (ko) * 2003-05-12 2013-01-31 아피맥스, 인크. 에리스로포이에틴 수용체에 결합하는 펩티드
CA2525464A1 (en) 2003-05-12 2004-11-25 Qun Yin Novel poly(ethylene glycol) modified compounds and uses thereof
EP2204193A3 (de) * 2003-05-12 2010-08-18 Affymax, Inc. Spacer-Bestandteile für Poly(ethylenglykol)-modifizierte Verbindungen auf Peptidbasis
CN101142234A (zh) * 2004-11-11 2008-03-12 阿费麦克斯公司 结合红细胞生成素受体的新肽
WO2006062685A2 (en) * 2004-11-11 2006-06-15 Affymax, Inc. Novel peptides that bind to the erythropoietin receptor
US20060257935A1 (en) * 2005-04-26 2006-11-16 Ajinomoto Co., Inc. Hematopoietic factor production promoter
US8324159B2 (en) * 2005-06-03 2012-12-04 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US7919461B2 (en) 2005-06-03 2011-04-05 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US7550433B2 (en) 2005-06-03 2009-06-23 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
DK2047863T3 (da) 2006-06-08 2013-09-16 Chugai Pharmaceutical Co Ltd Middel til forebyggelse eller behandling af inflammatoriske sygdomme
JP2010520855A (ja) * 2007-01-31 2010-06-17 アフィーマックス・インコーポレイテッド 修飾基をポリペプチドおよびその他の高分子に結合するための窒素ベースのリンカー
NZ579251A (en) 2007-02-28 2012-06-29 Schering Corp Engineered anti-il-23r antibodies
JP5337055B2 (ja) 2007-02-28 2013-11-06 メルク・シャープ・アンド・ドーム・コーポレーション 免疫性障害の処置のための組合せ治療
EP2288621A4 (de) * 2007-07-06 2012-01-04 Valorisation Hsj Soc En Commandite Il23-rezeptor-antagonisten und ihre verwendung
CN101939025B (zh) 2007-12-05 2015-03-25 中外制药株式会社 搔痒症治疗药
KR20150002874A (ko) 2008-05-05 2015-01-07 노비뮨 에스 에이 항-ｉｌ-１７ａ／ｉｌ-１７ｆ 교차-반응성 항체 및 그의 사용 방법
US20110158992A1 (en) * 2008-08-27 2011-06-30 Schering Corporation Engineered Anti-IL-23R Antibodies
EP2427203B1 (de) 2009-05-05 2018-10-17 Novimmune S.A. Anti-il-17f-antikörper und deren verwendung
CN102206667B (zh) * 2011-04-18 2012-10-10 中国药科大学 重组质粒pET32a-hIL-23R-CHR及其构建表达
TW202327654A (zh) 2015-04-14 2023-07-16 日商中外製藥股份有限公司 含有il-31拮抗劑作為有效成分之異位性皮膚炎的預防用及/或治療用醫藥組合物
EP3232000A1 (de) 2016-04-15 2017-10-18 Siemens Aktiengesellschaft Plattform einer laufschaufel mit filmkühlungsöffnungen an der plattform und zugehörige strömugsmaschine
JP6845973B1 (ja) 2019-11-20 2021-03-24 中外製薬株式会社 抗体含有製剤

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732863A (en) * 1984-12-31 1988-03-22 University Of New Mexico PEG-modified antibody with reduced affinity for cell surface Fc receptors
JP2898064B2 (ja) 1989-08-03 1999-05-31 忠三 岸本 ヒトｇｐ１３０蛋白質
GB9016440D0 (en) 1990-07-26 1990-09-12 Elopak Systems A laminate
US5783672A (en) 1994-05-26 1998-07-21 Immunex Corporation Receptor for oncostatin M
AUPN481295A0 (en) * 1995-08-16 1995-09-07 Medvet Science Pty. Ltd. Agonists of haemopoietic growth factors
AUPN564195A0 (en) * 1995-09-26 1995-10-19 Walter And Eliza Hall Institute Of Medical Research, The A novel haemopoietin receptor and genetic sequences encoding same
WO1997015663A1 (en) * 1995-10-23 1997-05-01 Amrad Operations Pty. Ltd. A novel haemopoietin receptor and genetic sequences encoding same
US6642360B2 (en) * 1997-12-03 2003-11-04 Genentech, Inc. Secreted polypeptides that stimulate release of proteoglycans from cartilage
US6747137B1 (en) * 1998-02-13 2004-06-08 Genome Therapeutics Corporation Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
WO1999067290A1 (fr) 1998-06-24 1999-12-29 Chugai Research Institute For Molecular Medicine, Inc. Nouvelles proteines receptrices d'hemopoïetine
DK1181366T4 (da) * 1999-06-01 2013-09-23 Merck Sharp & Dohme Mammale receptorproteiner, beslægtede reagenser og fremgangsmåder
US20030082734A1 (en) * 1999-06-01 2003-05-01 Dowling Lynette M. Mammalian receptor proteins; related reagents and methods
ES2339843T3 (es) 1999-06-02 2010-05-26 Chugai Seiyaku Kabushiki Kaisha Proteina receptora de hematopoyetina novedosa, nr10.
ES2254224T3 (es) * 1999-09-27 2006-06-16 Chugai Seiyaku Kabushiki Kaisha Nueva proteina del receptor de hematopoyetina, nr12.
ES2307618T3 (es) * 2000-05-10 2008-12-01 Schering Corporation Proteinas subunidades de receptores de cotocinas de mamiferos, reactivos y metodos relacionados.
WO2002000721A2 (en) 2000-06-26 2002-01-03 Zymogenetics, Inc. Cytokine receptor zcytor17
AU2318202A (en) 2000-10-06 2002-04-15 Immunex Corp Hematopoietin receptors hpr1 and hpr2
WO2002077230A1 (fr) 2001-03-26 2002-10-03 Chugai Seiyaku Kabushiki Kaisha Variants d'epissage nr10
BR0306979A (pt) 2002-01-18 2004-11-23 Zymogenetics Inc Polipeptìdeo isolado, proteìna de fusão, molécula isolada de polinucleotìdeo, vetor de expressão, célula cultivada, anticorpo ou fragmento de anticorpo, e, métodos para produzir uma proteìna, para produzir um anticorpo, para estimular uma resposta imune em um mamìfero, para expandir células hematopoiéticas e progenitores de células hematopoiéticas, para detectar a presença de rna zcytor17lig e de zcytor17lig em uma amostra biológica, para matar cérlulas cancerìgenas, para inibir a proliferação induzida por zcytor17lig ou diferenciação de células hematopoiéticas e progenitoras de células hematopoiéticas, para reduzir a inflamação induzida por zcytor17lig para suprimir uma resposta inflamatória em um mamìfero com inflamação, para tratar um mamìfero acometido por uma doença inflamatória e para detectar inflamação em um paciente
AU2003280410B8 (en) 2002-01-18 2009-04-23 Zymogenetics, Inc. Cytokine receptor zcytor17 multimers
SI1485477T1 (sl) 2002-02-25 2009-10-31 Genentech Inc Novi citokinski receptor GLM-R tipa 1
US7579000B2 (en) * 2002-05-01 2009-08-25 Bayer Schering Pharma Ag Tissue factor targeted antibodies as anticoagulants
CA2483909A1 (en) * 2002-05-01 2003-11-13 Schering Aktiengesellschaft Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
EP1671642A1 (de) 2004-12-15 2006-06-21 Universite D'angers Zusammensetzungen mit (Ant)agonisten von Oncostatin M (OSM), IL-31 und IFN-gamma zur Modulierung der Migration und Funktion von Keratinozyten via einen Rezeptor welcher OSMRbeta als Untereinheit enthält, und entprechende Anwendungen
AU2006207945B2 (en) 2005-01-28 2012-02-09 Zymogenetics, Inc. Homogeneous preparations of IL-31
EP1856539B1 (de) 2005-02-14 2015-10-21 ZymoGenetics, Inc. Verfahren zur vorhersage der therapeutischen reaktion auf il-31-antagonisten bei atopischer dermatitis
WO2006088855A1 (en) 2005-02-14 2006-08-24 Zymogenetics, Inc. Methods of treating skin disorders using an il-31ra antagonist
ES2561628T3 (es) 2005-05-06 2016-02-29 Zymogenetics, Inc. Anticuerpos monoclonales IL-31 y métodos de uso
CA2636288C (en) 2006-01-10 2015-02-24 Zymogenetics, Inc. Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
DK2047863T3 (da) * 2006-06-08 2013-09-16 Chugai Pharmaceutical Co Ltd Middel til forebyggelse eller behandling af inflammatoriske sygdomme
TWI434703B (zh) * 2007-05-14 2014-04-21 Kao Corp 皮膚洗淨劑組成物
JP5132292B2 (ja) * 2007-12-07 2013-01-30 キヤノン株式会社 情報処理装置および情報処理方法

Also Published As

Publication number Publication date
AU7445900A (en) 2001-04-30
WO2001023556A1 (fr) 2001-04-05
US20090105457A1 (en) 2009-04-23
EP1221482B1 (de) 2005-12-28
US20030009018A1 (en) 2003-01-09
US20090029484A1 (en) 2009-01-29
US20090105459A1 (en) 2009-04-23
DE60025241T2 (de) 2007-01-11
US7045595B2 (en) 2006-05-16
US20090023660A1 (en) 2009-01-22
US7893201B2 (en) 2011-02-22
ES2254224T3 (es) 2006-06-16
EP1221482A4 (de) 2003-03-26
US7893205B2 (en) 2011-02-22
US20070203328A1 (en) 2007-08-30
US20060106201A1 (en) 2006-05-18
US20090105458A1 (en) 2009-04-23
US20090111972A1 (en) 2009-04-30
EP1221482A1 (de) 2002-07-10

Similar Documents

Publication Publication Date Title
DE60025241D1 (de) HäMOPOIETINREZEPTOR-PROTEIN, NR12
DE60001530T2 (de) Verbinder
DE50007846D1 (de) Dreschkorb
MA25499A1 (fr) Contacteur-disjoncteur.
MA26849A1 (fr) 4-pyridinyle-n-acyl-l-phenylalanines.
DE60001032T2 (de) Verbinder
NO20013997L (no) Reseptoranalyse
DE60024400D1 (de) Empfangsgerät
ITBO990359A0 (it) Elettromandrino .
IT1310460B1 (it) Dispositivo gommatore .
DE60001783D1 (de) Verbinder
DE60003993D1 (de) Verbinder
DE60029755D1 (de) Congawandschutz.
ATE264301T1 (de) Muscarin-antagonisten
NO20021295L (no) Nikotinsyreacetylcholin-reseptor
ITBO990358A0 (it) Elettromandrino .
FI991256A0 (fi) Apulaite tarjoilua varten
ATE314472T1 (de) Hämopoietinrezeptor-protein, nr12
ES1044367Y (es) Piñata mejorada.
ES1044838Y (es) Friegasuelos.
DE29904541U1 (de) Steigbügel
ITSS990004V0 (it) Piramide - ricordo.
IT1313922B1 (it) Elettromandrino perfezionato.
ES1042809Y (es) Esponja-estropajo mejorado.
IT1311644B1 (it) Cerniera regolabile.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication of lapse of patent is to be deleted
8364 No opposition during term of opposition